[{"address1": "1489 West Warm Springs Road", "address2": "Suite 110", "city": "Henderson", "state": "NV", "zip": "89014", "country": "United States", "phone": "646 650 1351", "website": "https://www.volition.com", "industry": "Diagnostics & Research", "sector": "Healthcare", "longBusinessSummary": "VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 in the United States and internationally. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer for monitoring disease progression, response to treatment and minimal residual disease; Capture-PCR, an isolating and capturing circulating tumor derived DNA from plasma samples for early cancer detection; and Nu.Q Discover, a solution to profiling nucleosomes. VolitionRx Limited is based in Henderson, Nevada.", "fullTimeEmployees": 101, "companyOfficers": [{"maxAge": 1, "name": "Mr. Cameron  Reynolds MBA", "age": 52, "title": "Founder, CEO, President & Director", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 572434, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Gaetan  Michel Ph.D.", "age": 50, "title": "Chief Operating Officer", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 518149, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Salvatore Thomas Butera DVM", "age": 72, "title": "Chief Executive Officer of Volition Veterinary Diagnostics Development LLC", "yearBorn": 1951, "fiscalYear": 2023, "totalPay": 477253, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Terig  Hughes", "age": 53, "title": "CFO & Treasurer", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 338736, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jacob Vincent Micallef MBA, Ph.D.", "age": 67, "title": "Chief Scientific Officer", "yearBorn": 1956, "fiscalYear": 2023, "totalPay": 571554, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nicholas  Plummer", "age": 52, "title": "Group General Counsel", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Louise Batchelor  Day", "age": 52, "title": "Group Chief Marketing & Communications Officer", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gael  Forterre M.B.A.", "age": 42, "title": "Chief Commercial Officer", "yearBorn": 1981, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sharon  Ballesteros", "title": "U.S. Head of Quality & Development Process", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Andrew  Retter MBBS", "title": "Chief Medical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.5722, "open": 0.569, "dayLow": 0.5501, "dayHigh": 0.6324, "regularMarketPreviousClose": 0.5722, "regularMarketOpen": 0.569, "regularMarketDayLow": 0.5501, "regularMarketDayHigh": 0.6324, "beta": 1.103, "forwardPE": -3.93125, "volume": 242845, "regularMarketVolume": 242845, "averageVolume": 140158, "averageVolume10days": 229740, "averageDailyVolume10Day": 229740, "bid": 0.5949, "ask": 0.6325, "bidSize": 1000, "askSize": 800, "marketCap": 58286160, "fiftyTwoWeekLow": 0.43, "fiftyTwoWeekHigh": 1.23, "priceToSalesTrailing12Months": 59.68787, "fiftyDayAverage": 0.6848, "twoHundredDayAverage": 0.71775, "currency": "USD", "enterpriseValue": 61401916, "floatShares": 72455313, "sharesOutstanding": 92664800, "sharesShort": 441923, "sharesShortPriorMonth": 429740, "sharesShortPreviousMonthDate": 1727654400, "dateShortInterest": 1730332800, "sharesPercentSharesOut": 0.0047999998, "heldPercentInsiders": 0.2282, "heldPercentInstitutions": 0.19107, "shortRatio": 3.71, "shortPercentOfFloat": 0.0061000003, "bookValue": -0.095, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -32421484, "trailingEps": -0.36, "forwardEps": -0.16, "enterpriseToRevenue": 62.879, "enterpriseToEbitda": -1.94, "exchange": "ASE", "quoteType": "EQUITY", "symbol": "VNRX", "underlyingSymbol": "VNRX", "shortName": "VolitionRX Limited", "longName": "VolitionRx Limited", "firstTradeDateEpochUtc": 1330698600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "f2470521-bd30-36bc-8cb5-7a13c6a402d8", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.629, "targetHighPrice": 5.0, "targetLowPrice": 2.0, "targetMeanPrice": 3.13, "targetMedianPrice": 2.76, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 4, "totalCash": 5998928, "totalCashPerShare": 0.065, "ebitda": -31643828, "totalDebt": 5861053, "quickRatio": 0.199, "currentRatio": 0.237, "totalRevenue": 976516, "revenuePerShare": 0.012, "returnOnAssets": -1.00817, "freeCashflow": -5701370, "operatingCashflow": -17045064, "revenueGrowth": 0.83, "grossMargins": 1.0, "operatingMargins": -17.661629, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-12-07"}]